Our customers are researchers at large and mid-sized pharmaceutical companies, biotech pharma, academic labs, research institutes and hospitals, which develop anti-cancer drugs all over the world.
Why do our clients use our assays?
- Early-stage evaluation to eliminate low-value molecules before classical preclinical studies
- Very affordable cost compared to equivalent assays for in vivo results
- To save considerable time on their preclinical projects
- Minute amounts of compounds needed
- Wider possibilities for in vivo screening with the same budget
- We offer the initial in vivo proof of concept for your patents
- Generate the first in vivo data for your publications
- True in vivo assays, without animal experimentation
Many of our customers are repeat business after an initial assay.
They tell us there is a real added value in comparison to the classical preclinical model.
If you have questions or comments about our services, technologies and offers, feel free to contact us !